Daniel Leffler, Director of Research at the Celiac Center at Beth Israel Deaconess Medical CenterJack Maggiore, Head of Research and Development at Doctor's Data, Inc.
BIOGRAPHY
DEC 03, 2014 9:00 AM PST
Leveraging new technologies in gluten related disorders: Benefits before and after diagnosis
Abstract
Contemporary serologic testing has revolutionized the field of celiac disease. Highly accurate serologic assays have shown the prevalence of celiac disease to be nearly 1:100 in many populations. These commonly used tests allow noninvasive screening and detection. However, the variety of available serologic and genetic tests necessitates review of clinical utility as single tests or used in combination.
This presentation explores celiac disease and other gluten-related disorders, including updates on diagnostic algorithms and biomarkers, followed by an expert review of the BIO-FLASH system which utilizes chemiluminescent technology.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...